Description
GHRP-6 Peptide – Research-Grade Growth Hormone Secretagogue for Scientific Research.
GHRP-6 Peptide is a well-characterized synthetic growth hormone secretagogue composed of six amino acids with the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂. Developed to investigate mechanisms regulating pituitary hormone secretion, the peptide has become widely used in molecular biology, endocrinology, pharmacology, and receptor signaling research.
Unlike endogenous growth hormone-releasing hormone (GHRH), GHRP-6 Peptide primarily exerts its biological activity through selective activation of the growth hormone secretagogue receptor type 1a (GHS-R1a), a G protein-coupled receptor also recognized as the endogenous receptor for ghrelin. This receptor-mediated mechanism provides researchers with a valuable experimental model for studying intracellular signaling pathways, receptor pharmacodynamics, calcium-dependent signaling, phosphoinositide metabolism, and endocrine regulation.
The peptide is routinely incorporated into in vitro receptor assays, cell culture experiments, biochemical investigations, and laboratory models designed to characterize peptide-receptor interactions and downstream molecular responses. Because of its extensive scientific literature and reproducible pharmacological profile, GHRP-6 Peptide remains one of the most frequently referenced growth hormone secretagogues in endocrine research.
Appex Peptide Lab supplies high-purity research-grade GHRP-6 Peptide with strict manufacturing consistency and comprehensive analytical verification to support reliable laboratory outcomes.
For research use only. Not intended for human consumption or clinical use.
Key Research Highlights
- High-purity synthetic hexapeptide for laboratory research
- Verified amino acid sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂
- Potent agonist of the GHS-R1a receptor
- Widely studied in neuroendocrine signaling investigations
- Suitable for receptor-binding and pharmacology research
- Frequently utilized in intracellular calcium signaling studies
- Supports investigations of phosphoinositide and PKC signaling pathways
- Manufactured with rigorous analytical quality testing
- Supplied as a stable lyophilized research material
- Certificate of Analysis (COA) available
- Excellent batch-to-batch consistency
- Intended exclusively for scientific laboratory research
Why Researchers Choose This Product
- High analytical purity for reproducible experimental results
- Extensively characterized in peer-reviewed scientific literature
- Reliable GHS-R1a receptor agonist for molecular investigations
- Suitable for endocrine and receptor pharmacology studies
- Consistent manufacturing quality across production batches
- Comprehensive analytical documentation available
- Ideal for academic, biotechnology, and pharmaceutical laboratories
- Stable lyophilized formulation for laboratory storage
- Available in multiple research quantities
- For research use only. Not intended for human consumption or clinical use.
Research Applications

Growth Hormone Secretagogue Receptor Research
GHRP-6 Peptide is commonly employed to investigate ligand binding, receptor activation, receptor internalization, and downstream signaling mechanisms associated with the GHS-R1a receptor.
Neuroendocrine Signaling Studies
Researchers utilize GHRP-6 Peptide to explore endocrine communication pathways governing pituitary hormone regulation, neuropeptide signaling, and cellular communication.
Cell Signaling Investigations
The peptide serves as a valuable laboratory reagent for studying phospholipase C activation, intracellular calcium mobilization, protein kinase C signaling, MAPK activation, and secondary messenger systems.
Molecular Pharmacology
GHRP-6 Peptide is incorporated into receptor pharmacology experiments to characterize agonist potency, ligand selectivity, receptor kinetics, and signal transduction efficiency.
Cell Culture Research
Suitable for in vitro investigations involving pituitary-derived cell lines and recombinant expression systems evaluating peptide-mediated receptor responses.
Drug Discovery and Screening
Biotechnology and pharmaceutical laboratories use GHRP-6 Peptide during receptor assay development, compound screening, pharmacological validation, and peptide characterization studies.
Product Specifications
| Specification | Details |
|---|---|
| Purity | ≥99% (HPLC verified) |
| Molecular Formula | C₄₆H₅₆N₁₂O₆ |
| Molecular Weight | 873.01 g/mol |
| CAS Number | 87616-84-0 |
| Appearance | White to off-white lyophilized powder |
| Storage Conditions | Store lyophilized peptide at -20°C. After reconstitution, store according to validated laboratory protocols and avoid repeated freeze-thaw cycles. |
| Solubility | Soluble in sterile laboratory-grade water or appropriate aqueous research buffer |
| Sequence | His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂ |
| Available Sizes | 5 mg, 10 mg |
Mechanism of Action
GHRP-6 Peptide is a synthetic hexapeptide that functions as a selective agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a), a class A G protein-coupled receptor expressed in pituitary somatotrophs, hypothalamic neurons, and numerous peripheral tissues. In laboratory research, GHRP-6 Peptide is widely used to investigate receptor pharmacology, intracellular signaling mechanisms, endocrine regulation, and peptide-receptor interactions.
Upon binding to GHS-R1a, GHRP-6 Peptide primarily activates Gq/11-mediated signaling, leading to stimulation of phospholipase C (PLC). Activated PLC catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP₂), producing the intracellular second messengers inositol 1,4,5-trisphosphate (IP₃) and diacylglycerol (DAG). IP₃ promotes calcium release from intracellular endoplasmic reticulum stores, while DAG activates protein kinase C (PKC). Together, these signaling events regulate calcium-dependent exocytosis, transcriptional activity, and downstream cellular responses that are extensively investigated in endocrine research.
In addition to PLC signaling, GHRP-6 Peptide has been shown in experimental systems to influence multiple intracellular pathways including ERK1/2 (MAPK), PI3K/Akt, and calcium/calmodulin-dependent signaling networks. These pathways contribute to investigations examining receptor desensitization, gene transcription, receptor trafficking, phosphorylation events, and peptide-mediated cellular communication.
Unlike growth hormone-releasing hormone (GHRH), which primarily signals through adenylate cyclase and cyclic AMP (cAMP), GHRP-6 Peptide activates distinct intracellular mechanisms. Researchers frequently study the complementary relationship between these signaling pathways because simultaneous receptor activation has demonstrated coordinated cellular responses under controlled laboratory conditions. This makes GHRP-6 Peptide particularly valuable for experiments evaluating receptor crosstalk and integrated endocrine signaling.
Current molecular biology research also utilizes GHRP-6 Peptide to examine ligand-receptor binding kinetics, structure-activity relationships, receptor conformational dynamics, biased agonism, peptide stability, and downstream transcriptional regulation. These investigations continue to expand scientific understanding of GHS-R1a biology, peptide pharmacology, and intracellular signaling mechanisms across diverse experimental platforms.
For research use only. Not intended for human consumption or clinical use.




Reviews
There are no reviews yet.